Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
QuantumPharm, Inc. ( (HK:2228) ) has provided an update.
XtalPi Holdings Limited has successfully completed the placement of 264 million new shares under a general mandate, generating approximately HK$1,125 million in net proceeds. This placement increases the company’s issued share capital by about 7.18% and involves investment from professional and institutional investors, potentially strengthening XtalPi’s market position and financial resources.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., is a company incorporated in the Cayman Islands with limited liability. It operates within the pharmaceutical industry, focusing on innovative drug discovery and development, leveraging computational methods to enhance its research processes.
YTD Price Performance: -18.39%
Average Trading Volume: 88,507,579
Technical Sentiment Consensus Rating: Strong Buy
For detailed information about 2228 stock, go to TipRanks’ Stock Analysis page.
